{
    "refinement_output": "Based on the transcript, initial set of questions, and prior feedback, I have reviewed and refined the questions to ensure they align with the key concepts, enhance clarity and conciseness, and confirm distractors are plausible but incorrect. Here are the refined questions:\n\n1) In what year did the FDA clarify that prescription drug ads could run without including all risk information?\n    - A: 1980\n    - B: 1997\n    - C: 2004\n    - D: 2005\n[Correct answer]: B\n\n2) Which organization has called for a ban on direct-to-consumer prescription drug ads?\n    - A: American Medical Association\n    - B: Food and Drug Administration\n    - C: Supreme Court\n    - D: Pharmaceutical Research and Manufacturers of America\n[Correct answer]: A\n\n3) What led to the rise of direct-to-consumer prescription drug ads in the US?\n    - A: The shift in healthcare towards empowering patients to make decisions\n    - B: The FDA's initial regulations on prescription drug ads\n    - C: The Supreme Court's ruling on free speech protections\n    - D: The increasing cost of prescription medications\n[Correct answer]: A\n\n4) What is one potential drawback of prescription drug ads?\n    - A: They can contribute to unrealistic expectations about what pharmaceuticals can do\n    - B: They can improve communication between patients and doctors\n    - C: They can increase awareness of disease symptoms\n    - D: They can reduce the cost of prescription medications\n[Correct answer]: A\n\n5) What might happen if a patient sees a TV ad for a prescription drug and asks their doctor about it?\n    - A: The doctor will always refuse to prescribe the medication\n    - B: The doctor might be influenced by the patient's mention of the TV ad when making prescribing decisions\n    - C: The patient will always be prescribed a different medication\n    - D: The patient will never be prescribed any medication\n[Correct answer]: B\n\n6) Why might a pharmaceutical company use a TV ad campaign to promote a new drug?\n    - A: To decrease sales of the drug\n    - B: To increase awareness of the drug's risks and side effects\n    - C: To increase sales of the drug\n    - D: To educate doctors about the drug\n[Correct answer]: C\n\n7) What is one potential risk associated with prescription drug ads?\n    - A: They can lead to more communication between patients and doctors\n    - B: They can lead pharmaceutical companies to promote their products to a wider audience, potentially including people who don't need the medication\n    - C: They can reduce the cost of prescription medications\n    - D: They can improve health outcomes for all patients\n[Correct answer]: B\n\n8) What is one assumption underlying the argument in favor of prescription drug ads?\n    - A: That more communication between patients and doctors is always a bad thing\n    - B: That more communication between patients and doctors is always a good thing\n    - C: That prescription drug ads are too expensive to produce\n    - D: That prescription drug ads are only allowed for certain types of medications\n[Correct answer]: B\n\n9) What approach to prescription drug advertising might balance the need to educate patients with the need to protect them from potential harm?\n    - A: A ban on all prescription drug ads\n    - B: A balanced approach that both educates patients and protects them from potential harm\n    - C: A requirement that all prescription drug ads include all risk information\n    - D: A limit on the number of prescription drug ads that can be shown per day\n[Correct answer]: B\n\n10) What type of regulations might be proposed to limit the scope of TV ad campaigns for prescription drugs?\n    - A: Regulations that require more transparent risk information\n    - B: Regulations that limit the number of prescription drug ads that can be shown per day\n    - C: Regulations that ban all prescription drug ads\n    - D: Regulations that require pharmaceutical companies to promote their products to a wider audience\n[Correct answer]: A\n\n11) Is the current regulatory framework for prescription drug advertising in the US adequate?\n    - A: Yes, it is adequate\n    - B: No, it is not adequate and changes are needed to protect public health\n    - C: It is only adequate for certain types of medications\n    - D: It is only adequate for certain types of patients\n[Correct answer]: B\n\n12) Do the benefits of prescription drug ads outweigh the potential risks and drawbacks?\n    - A: Yes, the benefits outweigh the risks\n    - B: No, the risks outweigh the benefits\n    - C: The benefits and risks are equal\n    - D: It depends on the specific medication being advertised\n[Correct answer]: B\n\nAfter reviewing the questions, I did not find any significant issues that required major changes. However, I made some minor adjustments to improve clarity and conciseness. No more refinement needed."
}